Otsuka (OTCMKTS:OTSKY) Shares Gap Up – Time to Buy?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) gapped up before the market opened on Tuesday . The stock had previously closed at $32.07, but opened at $33.62. Otsuka shares last traded at $33.67, with a volume of 600 shares.

Analyst Upgrades and Downgrades

Several research firms have recently commented on OTSKY. UBS Group raised shares of Otsuka to a “hold” rating in a research note on Tuesday, January 27th. Zacks Research cut shares of Otsuka from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Finally, Morgan Stanley raised Otsuka to an “overweight” rating in a report on Friday, January 23rd. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Otsuka presently has a consensus rating of “Hold”.

Otsuka Price Performance

The stock’s 50-day moving average is $29.68 and its 200 day moving average is $28.14.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.